GILEAD SCIENCES, INC. is 22.4x more valuable than Arcellx, Inc. by market capitalization ($151.05 B vs $6.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACLX | GILD |
|---|---|---|
| Market cap | $6.73 B | $151.05 B |
| US-listed rank | #1180 | #99 |
| Revenue (latest FY) | $22.29M | $29.44B |
| Net income (latest FY) | -$228.93M | $8.51B |
| Net margin | -1027.3% | 28.9% |
| P/E (trailing FY) | - | 17.7 |
| SEC filings | 448 | 981 |
GILEAD SCIENCES, INC. is 22.4x more valuable than Arcellx, Inc. by market capitalization ($151.05 B vs $6.73 B).
In their latest fiscal years, Arcellx, Inc. reported $22.29M in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: Arcellx, Inc. and GILEAD SCIENCES, INC., or browse the full rankings.